If the control is the standard treatment then maybe nobody is being disadvantaged given our new intervention is only in trial stage and not proven - that's is all I can think of
ACL Price at posting:
58.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.